Palazestrant is an orally available, small molecule antagonist of estrogen receptor alpha (ERalpha; ERa; ESR1; nuclear receptor subfamily 3, group A, member 1; NR3A1) and a selective ER degrader (SERD), with potential antineoplastic activity. Upon oral administration, palazestrant competes with the endogenous activating estrogenic ligand 17-beta estradiol for binding in the ligand binding pocket of ERalpha, thereby inhibiting the activity of ERalpha. Palazestrant blocks estrogen-driven transcriptional activity and induces degradation of ERalpha. This inhibits the growth and survival of ERalpha-expressing cancer cells. ERalpha, a nuclear hormone receptor, is often overexpressed and/or mutated in a variety of cancer cell types. It plays a key role in tumor cell proliferation and survival. The directory classifies it as a clinical API with a synthetic source/manufacturing origin. Other names for this substance include OP-1250, 1H-Pyrido[3, 4-b]indole, 2-(2-fluoro-2-methylpropyl)-2, 3, 4, 9-tetrahydro-3-methyl-1-[4-[(1-propyl-3-azetidinyl)oxy]phenyl]-, (1R and 3R)-. Its PubChem CID is 135351887.
Palazestrant
| CAS No | 2092925-89-6 |
|---|---|
| Molecular Formula | C28H36FN3O |
| Molecular Weight | 449.6 g/mol |
| Synonyms | (1R,3R)-2-(2-fluoro-2-methylpropyl)-3-methyl-1-[4-(1-propylazetidin-3-yl)oxyphenyl]-1,3,4,9-tetrahydropyrido[3,4-b]indole |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Palazestrant is an orally available, small molecule antagonist of estrogen receptor alpha (ERalpha; ERa; ESR1; nuclear receptor subfamily 3, group A, member 1; NR3A1) and a selective ER degrader (SERD), with potential antineoplastic activity.
The listed CAS number is 2092925-89-6.
The listed molecular formula is C28H36FN3O.
The listed molecular weight is 449.6 g/mol.
(1R,3R)-2-(2-fluoro-2-methylpropyl)-3-methyl-1-[4-(1-propylazetidin-3-yl)oxyphenyl]-1,3,4,9-tetrahydropyrido[3,4-b]indole.
The source lists OP-1250, 1H-Pyrido[3, 4-b]indole, 2-(2-fluoro-2-methylpropyl)-2, 3, 4, 9-tetrahydro-3-methyl-1-[4-[(1-propyl-3-azetidinyl)oxy]phenyl]-, (1R and 3R)-.